Total Return chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.045 USD | +1.46% |
|
-7.89% | -37.13% |
| 07-14 | Lineage Cell Therapeutics, Inc. - Special Call | |
| 07-13 | Lineage Cell Therapeutics Provides Update On COR1 Cell Therapy Program For Corneal Endothelial Disease | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
















